Post by portfoliomgmt23 on Apr 14, 2023 13:17:29 GMT
Hi All,
I’m new to the board but was bite by the biotech bug a few years back. Retail investor who is currently excited about the near term prospects for PLX-102 and its potential approvals from the EMA and FDA. The stock has enjoyed a nice run this year and I’m thinking that both approvals move it from $2.50 to $6+.
My basic research shows the hat drugs w/ CHMP recommendations gain approval at a high percentage, which is helping me steady my hands on this one. Do any of you follow Protalix or have insights pro or con to share? I welcome the conversation.
I’m new to the board but was bite by the biotech bug a few years back. Retail investor who is currently excited about the near term prospects for PLX-102 and its potential approvals from the EMA and FDA. The stock has enjoyed a nice run this year and I’m thinking that both approvals move it from $2.50 to $6+.
My basic research shows the hat drugs w/ CHMP recommendations gain approval at a high percentage, which is helping me steady my hands on this one. Do any of you follow Protalix or have insights pro or con to share? I welcome the conversation.